Ping An Biomedical Co. Issues Letter Regarding Nasdaq Minimum Bid Price Deficiency
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 28 2025
0mins
Nasdaq Deficiency Letter: Ping An Biomedical Co. received a letter from Nasdaq indicating it no longer meets the minimum bid price requirement due to its stock price falling below $1 per share.
Compliance Period: The company has been granted a compliance period of 180 calendar days, until May 25, 2026, to regain compliance with Nasdaq's listing requirements.
Analyst Views on PASW
About PASW
Ping An Biomedical Co Ltd, formerly known as Majestic Ideal Holdings Ltd, is an investment holding company mainly engaged in the provision of apparel supply chain management services (SCM services). The Company operates its business through two segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. The Company provides end-to-end supply chain solutions. The Company provides services covering functions within the supply chain of these products, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
